Table 3.
No Pill | Unblinded Echinacea |
Blinded Placebo |
Blinded Echinacea |
Between Blinded Group Differences |
|
---|---|---|---|---|---|
Biomarker Data | n=164 | n=171 | n=168 | n=170 | |
Median change IL-8 (95% CI) | 30 (2–89) | 70 (18–134) | 39 (12–106) | 58 (18–105) | 19.0 (−75.2, 72.0) |
Median change neutrophils (95%CI) | 1 (−1–4) | 1 (0–4) | 1 (−1–4) | 2 (0–5) | 1.0 (−4.0, 3.0) |
Self-report data (mean) | n=174 | n=182 | n=179 | n=184 | |
Physical health SF-8 (95%CI) | 48.0 (47.1–49.0) | 47.7 (46.8–48.6) | 46.9 (45.9–48.0) | 47.3 (46.2–48.4) | 0.40 (−1.13, 1.93) |
Mental health SF-8 (95%CI) | 43.8 (42.3–45.3) | 43.7 (42.2–45.2) | 42.5 (41.0–43.9) | 44.4 (43.1–45.7) | 1.90 (−0.06, 3.86) |
Feeling thermometer (95%CI) | 60.3 (57.9–62.9) | 62.5 (59.7–65.3) | 62.5 (59.5–65.5) | 63.6 (60.8–66.4) | 1.10 (−2.88, 5.08) |
Stress (PSS-4) (95%CI) | 4.3 (3.9–4.8) | 4.5 (4.1–4.9) | 4.6 (4.1–5.0) | 4.5 (4.0–5.0) | 0.10 (−0.76, 0.56) |
Stress (VAS) (95%CI) | 38.3 (34.3–42.3) | 40.0 (36.2–43.8) | 38.0 (34.5–41.5) | 36.6 (32.9–40.3) | 1.40 (−6.33, 3.53) |
Optimism (LOT-6) (95%CI) | 22.7 (22.1–23.4) | 22.9 (22.4–23.6) | 22.1 (21.5–22.7) | 23.1 (22.5–23.7) | 1.00 (0.16, 1.84) |
Social support (Ryff PR) (95%CI) | 45.1 (44.1–46.3) | 45.6 (44.6–46.8) | 44.5 (43.1–45.6) | 45.4 (44.2–46.4) | 0.90 (−0.65, 2.45) |
Values for IL-8 and neutrophil count are median change from Day 1 intake to Day 3
Neutrophil counts are number of cells per high power field
IL-8 units are pg/mL